tetano
Editor, Senior Moderator
Vaccine
. 2024 Feb 24:S0264-410X(24)00113-0.
doi: 10.1016/j.vaccine.2024.01.089. Online ahead of print. The association between influenza vaccination uptake and influenza and pneumonia-associated deaths in the United States
Anthony T Newall[SUP] 1 [/SUP], Allen L Nazareno[SUP] 2 [/SUP], David J Muscatello[SUP] 3 [/SUP], David Boettiger[SUP] 4 [/SUP], Cécile Viboud[SUP] 5 [/SUP], Lone Simonsen[SUP] 6 [/SUP], Robin M Turner[SUP] 7 [/SUP]
Affiliations
Background: The influenza mortality burden has remained substantial in the United States (US) despite relatively high levels of influenza vaccine uptake. This has led to questions regarding the effectiveness of the program against this outcome, particularly in the elderly. The aim of this evaluation was to develop and explore a new approach to estimating the population-level effect of influenza vaccination uptake on pneumonia and influenza (P&I) associated deaths.
Methods: Using publicly available data we examined the association between state-level influenza vaccination and all-age P&I associated deaths in the US from the 2013-2014 influenza season to the 2018-2019 season. In the main model, we evaluated influenza vaccine uptake in all those age 6 months and older. We used a mixed-effects regression analysis with generalised least squares estimation to account for within state correlation in P&I mortality.
Results: From 2013-2014 through 2018-2019, the total number of all-age P&I related deaths during the influenza seasons was 480,111. The mean overall cumulative influenza vaccine uptake (age 6 months and older) across the states and years considered was 46.7%, with higher uptake (64.8%) observed in those aged ≥ 65 years. We found that overall influenza vaccine uptake (6 months and older) had a statistically significant protective association with the P&I death rate. This translated to a 0.33 (95% CI: 0.20, 0.47) per 100,000 population reduction in P&I deaths in the influenza season per 1% increase in overall influenza vaccine uptake.
Discussion: These results using a population-level statistical approach provide additional support for the overall effectiveness of the US influenza vaccination program. This reassurance is critical given the importance of ensuring confidence in this life saving program. Future research is needed to expand on our approach using more refined data.
Keywords: Ecological study; Effectiveness; Influenza; Influenza vaccine; Mortality.
. 2024 Feb 24:S0264-410X(24)00113-0.
doi: 10.1016/j.vaccine.2024.01.089. Online ahead of print. The association between influenza vaccination uptake and influenza and pneumonia-associated deaths in the United States
Anthony T Newall[SUP] 1 [/SUP], Allen L Nazareno[SUP] 2 [/SUP], David J Muscatello[SUP] 3 [/SUP], David Boettiger[SUP] 4 [/SUP], Cécile Viboud[SUP] 5 [/SUP], Lone Simonsen[SUP] 6 [/SUP], Robin M Turner[SUP] 7 [/SUP]
Affiliations
- PMID: 38403498
- DOI: 10.1016/j.vaccine.2024.01.089
Background: The influenza mortality burden has remained substantial in the United States (US) despite relatively high levels of influenza vaccine uptake. This has led to questions regarding the effectiveness of the program against this outcome, particularly in the elderly. The aim of this evaluation was to develop and explore a new approach to estimating the population-level effect of influenza vaccination uptake on pneumonia and influenza (P&I) associated deaths.
Methods: Using publicly available data we examined the association between state-level influenza vaccination and all-age P&I associated deaths in the US from the 2013-2014 influenza season to the 2018-2019 season. In the main model, we evaluated influenza vaccine uptake in all those age 6 months and older. We used a mixed-effects regression analysis with generalised least squares estimation to account for within state correlation in P&I mortality.
Results: From 2013-2014 through 2018-2019, the total number of all-age P&I related deaths during the influenza seasons was 480,111. The mean overall cumulative influenza vaccine uptake (age 6 months and older) across the states and years considered was 46.7%, with higher uptake (64.8%) observed in those aged ≥ 65 years. We found that overall influenza vaccine uptake (6 months and older) had a statistically significant protective association with the P&I death rate. This translated to a 0.33 (95% CI: 0.20, 0.47) per 100,000 population reduction in P&I deaths in the influenza season per 1% increase in overall influenza vaccine uptake.
Discussion: These results using a population-level statistical approach provide additional support for the overall effectiveness of the US influenza vaccination program. This reassurance is critical given the importance of ensuring confidence in this life saving program. Future research is needed to expand on our approach using more refined data.
Keywords: Ecological study; Effectiveness; Influenza; Influenza vaccine; Mortality.